Benign prostatic hyperplasia: BPH drugs versus Dr Allen’s Device

The Global Treatment Market of Benign prostatic hyperplasia (BPH) was valued at $10,688.72 million in 2017 and is projected to reach $20,096.68 million by 2025 at a CAGR of 8.1% from 2018 to 2025.

Thermobalancing therapy with Dr Allen’s Device was patented by the United States Patent and Trademark Office. Over a decade, thousands of men with BPH used or are using this non-invasive and side-effects free Dr Allen’s Device. Fine Treatment, an innovative healthcare company, http://finetreatment.com, is an international distributor of wearable Dr Allen’s Device.

However, Fine Treatment was not among more than 100 industries listed in Market-research study 2019. It looks strange but competitors do not want to have strong opponent between them and even try to blacklist with the help of Google search suggestion.

Innovative natural Thermobalancing therapy compares preferably than risky drugs offered by imminent companies such as Pfizer, Sanofi, GlaxoSmithKline, Boston Scientific, Teleflex, Cardinal Health, Allergan, and others.

How many men can be a target for the treatment of BPH?

Benign prostatic hyperplasia (BPH) is an extremely common and expensive disease that affects older men around the world. BPH can be diagnosed in approximately 50 percent of men aged 51 to 60 and up to 90 percent of men over 80 in the United States.

In China, the prevalence of symptoms of urination due to an enlarged prostate - BPH was recorded in approximately 15% of men aged 70 years, but due to the large population, the total number of men is equal to the United States. More than 5 million men over 65 in Spain are at risk for bladder obstruction due to an enlarged prostate. 1 million men over 65 in Pakistan are at risk for problems with blockage of the bladder due to BPH.

Most men with BPH suffer from lower urinary tract symptoms (LUTS), which include: frequent urination during the day and at night, urgency to urinate, poor urine outflow and urinary incontinence, etc. Since BPH is not a life-threatening condition, it should be treated safely. Nevertheless, since the number of men with an enlarged prostate is huge, manufacturers of drugs for BPH are trying to fill the market for this disease with various drugs, despite the fact that they are dangerous to men's health.

BPH drugs can harm the health of men

Medications produced by different companies for the treatment of BPH are similar:
1. Alpha blockers, which relax the muscle of the prostate and bladder neck that allows urine to flow more easily, tamsulosin, terazosin, etc. These drugs can be responsible for tiredness, sexual dysfunction, headache, dizziness and even dementia;
2. 5 alpha reductase inhibitors - hormonal drugs: finasteride (Proscar), dutasteride (Avodart) responsible for irreversible side effects: impotence, depression, testicle pain, and even diabetes.

However, these drugs: Alpha blockers and 5 alpha reductase inhibitors are often prescribed to men with BPH together, as so-called combination therapy. This therapy doubles the risks of BPH drugs for men’s health.

It is important to know. as a French population‐based study, published in 2019: “Use of 5α-reductase inhibitors for benign prostate hypertrophy and risk of high-grade prostate cancer” concluded that patients treated for >2 years with 5α-reductase inhibitors should be informed about the increased risk of development of high-grade prostate cancer.

Thermobalancing therapy is approved by medical scientific data

Over 10-year long empirical evidence strongly suggest that Dr Allen's Device helps men with BPH reduce enlarge prostate volume and, consequently, urination symptoms. A clinical study on Thermobalancing therapy confirmed the effectiveness of Dr Allen's device in 124 men with BPH. Many scientific articles were published in leading medical journals,
https://finetreatment.com/thermobalancing-therapy-medical-scientific-data/.

For instance, a scientific article: "Use of Thermobalancing therapy in ageing male with benign prostatic hyperplasia with a focus on etiology and pathophysiology,” in Aging Male Journal explains the cause of prostate enlargement, and the best way to treat it.

Another article: Thermobalancing conservative treatment for moderate-to-low-degree lower urinary tract symptoms (LUTS) secondary to prostate enlargement concluded that positive effect of therapeutic device for BPH has allowed us to recommend this side-effect-free therapy in watchful waiting or active surveillance approach.

Dr Allen's Device, which applies a natural thermoelement to the skin, is a class 1 medical device, which does not require the involvement of a notified body. So, everyone can use this device at home without worrying, as this treatment option causes no side effects. The delivery of Dr Allen's Device is guaranteed by Royal mail tracking services.

In contrast to all other treatments, Dr Allen’s Device, with the price less than $ 200, provides cost-effective therapy. The price of delivery is included in the total price of the device. For most men, this is a one-time purchase, since the device works for at least a year.



This release was published on openPR.